Caricamento quotazioni...
Previsioni
| Acquista |
1 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Altro su de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Altro su de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | settembre 2025 | YoY |
|---|---|---|
| Ricavi | 68,1 Mln | - |
| Utile lordo | 19,52 Mln | - |
| Utile netto | -12,15 Mln | - |
| EBITDA | 6,65 Mln | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 12,92 Mln € |
Numero di azioni | 497,46 Mln |
Massimo/minimo a 52 settimane | 0,14 € - 0,0178 € |
| Dividendi | No |
Beta | 1,05 |
Rapporto P/E | -0,15 |
Rapporto PEG | 0,00 |
Rapporto P/B | -0,10 |
Rapporto P/S | 0,09 |
Profilo aziendale
The Cannabist Company Holdings Inc. si occupa della coltivazione, produzione e fornitura di prodotti a base di cannabis e di servizi correlati negli Stati Uniti e a livello internazionale. La società offre prodotti che spaziano da fiori, edibles, oli e compresse, commercializzati con i marchi Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press e Amber. Detiene licenze in 17 giurisdizioni negli Stati Uniti. In precedenza la società era nota come Columbia Care Inc. e ha cambiato il proprio nome in The Cannabist Company Holdings Inc. nel settembre 2023. La società è stata fondata nel 2012 ed ha sede a New York, New York.
| Nome | Cannabist Co. Holdings Aktie |
| CEO | Christopher Marr |
| Sede centrale | Malvern,
pa Stati Uniti |
| Sito web | |
| Quotazione in borsa | 29/04/2019 |
| Dipendenti | 2829 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |